Long Covid: NHS legal action launched by family of girl
The mother of an 11-year-old Aberdeenshire girl claims failings were made by NHS Grampian.
Similar Posts
Marine vet advocates for psychedelic-assisted PTSD therapies, as FDA drug application is filed for MDMA
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Sleep disruptions due to night sweats: When should you see a doctor?
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Measles vaccine campaign targets unprotected millions
More than three million children under 16 are at risk of becoming ill, NHS England says.
Covid jab skipped by 44%, entire UK study finds
More than 7,000 hospital admissions could have been prevented in summer 2022 with full protection.
Humana reports grim 2024 forecast due to soaring medical costs
Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Sunday, Feb. 3, 2019. Humana is scheduled to release earnings figures on February 6. Photographer: Luke Sharrett/Bloomberg via Getty Images Bloomberg | Bloomberg | Getty Images Shares of Humana plummeted on Thursday after the health insurer issued dismal full-year earnings guidance,…
Walgreens and 3 other health-care stocks are going into our Bullpen watch list
We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful of company CEOs Jim interviewed at this week’s JPMorgan…